US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS

282.29

-5.0400-1.75%

Post-market: 286.604.31+1.53%18:59 EDT

Volume:407.11K

Turnover:115.19M

Market Cap:31.33B

PE:542.45

High:286.87

Open:286.87

Low:281.04

Close:287.33

52wk High:385.22

52wk Low:196.45

Shares:111.00M

Float Shares:85.58M

Volume Ratio:1.91

T/O Rate:0.48%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.5204

EPS(LYR):2.47

ROE:7.46%

ROA:3.96%

PB:7.18

PE(LYR):114.29

Loading ...

Overview Company News Filings

Stock Track | BEIGENE Plummets 7.45% in Pre-market on Earnings Caution and Below-Guide Revenue Outlook

Beigene Turns Profit with Strong 2025 Results

BEIGENE Reports Robust 2025 Performance with Adjusted Net Profit of Approximately $918 Million, Turning Around from Loss

GUIDANCE: (ONC) BeOne Medicines Expects 2026 Revenue Range $6.2B to $6.4B, vs. FactSet Est of $6.41B

MT Newswires Live

Press Release: BeOne Medicines Announces Fourth Quarter and Full Year 2025 Financial Results, Highlighting Global Success of BRUKINSA and Foundational Oncology Leadership

Stock Track | BEIGENE Plunges 6.88% in Pre-market Ahead of 2025 Financial Report Release

Stock Track | BEIGENE Plunges 6.83% in 24-Hour Session Ahead of Earnings Report Release

Biotech Stocks Lead Declines as BEIGENE Slumps Over 6% Ahead of Earnings

BeOne Medicines AG expected to post earnings of $1.21 a share - Earnings Preview

Earning Preview: BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS this quarter’s revenue is expected to increase by 39.70%, and institutional views are bullish

Press Release: BeOne Medicines to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26

Is BeOne Medicines (ONC) Using InSysBio Partnership to Quietly Redefine Its R&D Risk Strategy?

Simply Wall St.

Beone Medicines : Barclays Raises Target Price to $394 From $385

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and BeOne Medicines (ONC)

U.S. RESEARCH ROUNDUP- Ametek, Coca-Cola, Pepsico

BeOne Medicines Extends InSysBio Tie Up To Refine Oncology Trial Dosing

Simply Wall St.

Is There Now An Opportunity In BeOne Medicines (ONC) After Strong Multi‑Year Share Gains

Simply Wall St.

Valuation Ranges of Biopharma: Insights from Innovent Biologics, Hengrui Pharmaceuticals, and BeiGene

BeiGene (06160) Grants Restricted Stock Units Involving 21,000 American Depositary Shares

Did BeOne’s New Uptrend And Upgraded Earnings Outlook Just Shift Its (ONC) Investment Narrative?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ONC/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ONC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONC\",,,,,undefined,":{"symbol":"ONC","market":"US","secType":"STK","nameCN":"BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS","latestPrice":282.29,"timestamp":1773864000000,"preClose":287.33,"halted":0,"volume":407112,"hourTrading":{"tag":"盘后","latestPrice":286.6,"preClose":282.29,"latestTime":"18:59 EDT","volume":3571,"amount":1008515.87,"timestamp":1773874784860,"change":4.31,"changeRate":0.015268,"amplitude":0.01626},"delay":0,"changeRate":-0.017540806737897065,"floatShares":85577300,"shares":111000000,"eps":0.5204,"marketStatus":"Closed","change":-5.04,"latestTime":"03-18 16:00:00 EDT","open":286.87,"high":286.87,"low":281.04,"amount":115189474.33152,"amplitude":0.02029,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.5204,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1773907200000},"marketStatusCode":5,"adr":0,"adrRate":13,"exchange":"NASDAQ","adjPreClose":287.33,"preHourTrading":{"tag":"盘前","latestPrice":286.54,"preClose":287.33,"latestTime":"09:29 EDT","volume":9011,"amount":2589844.3012,"timestamp":1773840599999,"change":-0.79,"changeRate":-0.002749,"amplitude":0.011624},"postHourTrading":{"tag":"盘后","latestPrice":286.6,"preClose":282.29,"latestTime":"18:59 EDT","volume":3571,"amount":1008515.87,"timestamp":1773874784860,"change":4.31,"changeRate":0.015268,"amplitude":0.01626},"volumeRatio":1.910606,"impliedVol":0.4135,"impliedVolPercentile":0.247},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONC\",,,,,undefined,":{"symbol":"ONC","floatShares":85577300,"roa":"3.96%","roe":"7.46%","lyrEps":2.469999,"volumeRatio":1.910606,"shares":111000000,"dividePrice":0,"high":286.87,"amplitude":0.02029,"preClose":287.33,"low":281.04,"week52Low":196.45,"pbRate":"7.18","psRate":"5.86","week52High":385.22,"institutionHeld":0,"latestPrice":282.29,"eps":0.5204,"divideRate":0,"volume":407112,"delay":0,"ttmEps":0.5204,"open":286.87,"prevYearClose":303.81,"prevWeekClose":284.05,"prevMonthClose":316.99,"prevQuarterClose":303.81,"fiveDayClose":298.91,"twentyDayClose":359.05,"sixtyDayClose":307.02},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ONC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-26","symbol":"ONC","fiscalQuarterEnding":"2025/12","expectedEps":1.6,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"pre","actualEps":0.58},{"market":"US","date":"2025-11-06","symbol":"ONC","fiscalQuarterEnding":"2025/09","expectedEps":0.72,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":1.09},{"date":"2025-08-30","symbol":"ONC","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756540800000,"name":null,"time":"Pre-Market","dateTimestamp":1756526400000,"actualEps":null},{"market":"US","date":"2025-05-07","symbol":"ONC","fiscalQuarterEnding":"2025/03","expectedEps":-0.71,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"pre","actualEps":1.22},{"market":"US","date":"2025-02-27","symbol":"ONC","fiscalQuarterEnding":"2024/12","expectedEps":-0.88,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":-1.43}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ONC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ONC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.6667,"hold":0.0417,"sell":0.0417,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":24,"updateTime":1773633600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ONC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ONC","date":"2026-03-17","current":542.448117,"percent":0.813747,"low":-217.585346,"twenty":-80.757951,"median":-38.863214,"eighty":-19.498872,"high":609.337035,"avg":35.32951,"sd":234.706517,"marketCap":32118148147},"quantilePoints":[{"date":"2024-05-31","current":-19.860847,"twenty":-20.46703,"median":-20.284421,"eighty":-20.042184,"marketCap":15579384952},{"date":"2024-06-07","current":-20.864085,"twenty":-20.930269,"median":-20.558927,"eighty":-20.042184,"marketCap":16366351618},{"date":"2024-06-14","current":-21.694058,"twenty":-21.409839,"median":-20.844737,"eighty":-20.30869,"marketCap":17017405001},{"date":"2024-06-21","current":-20.966373,"twenty":-21.331475,"median":-20.876952,"eighty":-20.46703,"marketCap":16446589390},{"date":"2024-06-28","current":-19.234246,"twenty":-21.331475,"median":-20.825389,"eighty":-19.981739,"marketCap":15087861974},{"date":"2024-07-05","current":-19.83401,"twenty":-21.208618,"median":-20.693442,"eighty":-19.760805,"marketCap":15558333278},{"date":"2024-07-12","current":-20.525989,"twenty":-21.135228,"median":-20.465877,"eighty":-19.641074,"marketCap":16101139655},{"date":"2024-07-19","current":-20.872652,"twenty":-21.016911,"median":-20.525989,"eighty":-19.707798,"marketCap":16373071895},{"date":"2024-07-26","current":-21.924783,"twenty":-21.374239,"median":-20.660298,"eighty":-19.760805,"marketCap":17198391533},{"date":"2024-08-02","current":-22.081827,"twenty":-21.704901,"median":-20.777003,"eighty":-19.839377,"marketCap":17321581561},{"date":"2024-08-09","current":-37.033118,"twenty":-22.009534,"median":-20.868368,"eighty":-19.874904,"marketCap":19394058972},{"date":"2024-08-16","current":-39.443432,"twenty":-22.36867,"median":-20.966373,"eighty":-19.937065,"marketCap":20656328240},{"date":"2024-08-23","current":-39.274234,"twenty":-33.284244,"median":-21.171036,"eighty":-20.00126,"marketCap":20567720015},{"date":"2024-08-30","current":-38.860864,"twenty":-37.912544,"median":-21.248991,"eighty":-20.190606,"marketCap":20351240040},{"date":"2024-09-06","current":-38.812817,"twenty":-38.506257,"median":-21.456019,"eighty":-20.300725,"marketCap":20326078245},{"date":"2024-09-13","current":-40.29759,"twenty":-38.865563,"median":-21.710093,"eighty":-20.355918,"marketCap":21103646159},{"date":"2024-09-20","current":-41.008162,"twenty":-39.353261,"median":-21.954664,"eighty":-20.405766,"marketCap":21475769498},{"date":"2024-09-27","current":-44.343793,"twenty":-39.883427,"median":-22.072098,"eighty":-20.507104,"marketCap":23222622772},{"date":"2024-10-04","current":-49.961787,"twenty":-40.117185,"median":-22.410559,"eighty":-20.525989,"marketCap":26164738255},{"date":"2024-10-11","current":-47.875901,"twenty":-40.317892,"median":-22.855632,"eighty":-20.558927,"marketCap":25072369873},{"date":"2024-10-18","current":-44.402313,"twenty":-41.008162,"median":-37.033118,"eighty":-20.627155,"marketCap":23253269086},{"date":"2024-10-25","current":-43.1532,"twenty":-43.068033,"median":-37.882149,"eighty":-20.693442,"marketCap":22599114920},{"date":"2024-11-01","current":-41.429716,"twenty":-43.148001,"median":-38.271158,"eighty":-20.724275,"marketCap":21696535276},{"date":"2024-11-08","current":-41.685343,"twenty":-43.068033,"median":-38.746669,"eighty":-20.777003,"marketCap":21830405481},{"date":"2024-11-15","current":-24.188369,"twenty":-42.835701,"median":-38.506257,"eighty":-20.825389,"marketCap":20104967290},{"date":"2024-11-22","current":-24.46985,"twenty":-42.494274,"median":-38.062423,"eighty":-20.864085,"marketCap":20240962418},{"date":"2024-11-29","current":-27.613239,"twenty":-42.262623,"median":-37.45966,"eighty":-20.870939,"marketCap":22851200825},{"date":"2024-12-06","current":-26.519964,"twenty":-42.078114,"median":-35.811244,"eighty":-20.886386,"marketCap":21862847938},{"date":"2024-12-13","current":-23.158686,"twenty":-41.984053,"median":-26.690447,"eighty":-20.951062,"marketCap":19077141333},{"date":"2024-12-20","current":-22.876382,"twenty":-41.961072,"median":-26.519964,"eighty":-21.016911,"marketCap":18791641889},{"date":"2024-12-27","current":-23.581122,"twenty":-41.848457,"median":-25.970587,"eighty":-21.108807,"marketCap":19365505627},{"date":"2025-01-03","current":-23.522344,"twenty":-41.738903,"median":-25.015322,"eighty":-21.169159,"marketCap":19262068568},{"date":"2025-01-10","current":-23.039426,"twenty":-41.667895,"median":-24.95255,"eighty":-21.188412,"marketCap":18831625271},{"date":"2025-01-17","current":-27.361812,"twenty":-41.564427,"median":-24.990614,"eighty":-21.226086,"marketCap":22387798297},{"date":"2025-01-24","current":-28.60727,"twenty":-41.429716,"median":-25.817461,"eighty":-21.248991,"marketCap":23666613889},{"date":"2025-01-31","current":-29.006926,"twenty":-41.129457,"median":-26.292693,"eighty":-21.405551,"marketCap":23976726670},{"date":"2025-02-07","current":-29.003485,"twenty":-41.095232,"median":-26.532547,"eighty":-21.456019,"marketCap":23849552911},{"date":"2025-02-14","current":-29.812673,"twenty":-41.008162,"median":-26.754345,"eighty":-21.694058,"marketCap":24634934161},{"date":"2025-02-21","current":-32.964646,"twenty":-40.974605,"median":-27.361812,"eighty":-21.704901,"marketCap":27250381776},{"date":"2025-02-28","current":-45.085214,"twenty":-41.025576,"median":-28.423545,"eighty":-21.711581,"marketCap":29070314911},{"date":"2025-03-07","current":-41.087466,"twenty":-41.189509,"median":-28.729221,"eighty":-21.882341,"marketCap":26492622821},{"date":"2025-03-14","current":-43.209977,"twenty":-41.608729,"median":-28.790129,"eighty":-21.948688,"marketCap":27861188167},{"date":"2025-03-21","current":-42.024306,"twenty":-41.961072,"median":-29.003485,"eighty":-22.009534,"marketCap":27096684166},{"date":"2025-03-28","current":-44.59433,"twenty":-42.028738,"median":-29.052749,"eighty":-22.054545,"marketCap":28753799426},{"date":"2025-04-04","current":-39.846019,"twenty":-42.270172,"median":-29.231496,"eighty":-22.077935,"marketCap":25692155286},{"date":"2025-04-11","current":-38.484462,"twenty":-42.209323,"median":-29.379987,"eighty":-22.177258,"marketCap":24814242135},{"date":"2025-04-17","current":-38.603,"twenty":-42.109763,"median":-29.75631,"eighty":-22.326782,"marketCap":24890673891},{"date":"2025-04-25","current":-40.929408,"twenty":-42.213935,"median":-30.85745,"eighty":-22.4234,"marketCap":26390709308},{"date":"2025-05-02","current":-42.799955,"twenty":-42.322726,"median":-33.161649,"eighty":-22.493794,"marketCap":27596811853},{"date":"2025-05-09","current":-63.824658,"twenty":-42.611855,"median":-33.528671,"eighty":-22.601969,"marketCap":25042625921},{"date":"2025-05-16","current":-62.94985,"twenty":-42.804476,"median":-34.892623,"eighty":-22.71748,"marketCap":24699380815},{"date":"2025-05-23","current":-72.041871,"twenty":-43.150081,"median":-36.84391,"eighty":-22.787779,"marketCap":28266780880},{"date":"2025-05-30","current":-74.527648,"twenty":-43.429182,"median":-37.087829,"eighty":-22.808465,"marketCap":29242115209},{"date":"2025-06-06","current":-77.688492,"twenty":-43.794804,"median":-38.030583,"eighty":-22.84042,"marketCap":30482322820},{"date":"2025-06-13","current":-89.808695,"twenty":-44.177303,"median":-38.271158,"eighty":-22.941372,"marketCap":35237878321},{"date":"2025-06-20","current":-76.439732,"twenty":-44.40516,"median":-38.484462,"eighty":-23.038971,"marketCap":29992352055},{"date":"2025-06-27","current":-76.95683,"twenty":-44.800569,"median":-38.641761,"eighty":-23.063278,"marketCap":30195243589},{"date":"2025-07-03","current":-74.11053,"twenty":-45.138397,"median":-38.836841,"eighty":-23.158686,"marketCap":29078452032},{"date":"2025-07-11","current":-76.495446,"twenty":-45.905367,"median":-39.006759,"eighty":-23.171606,"marketCap":30014212230},{"date":"2025-07-18","current":-87.653233,"twenty":-47.435675,"median":-39.313748,"eighty":-23.176246,"marketCap":34392148550},{"date":"2025-07-25","current":-89.648478,"twenty":-48.541013,"median":-39.640999,"eighty":-23.189441,"marketCap":35175014575},{"date":"2025-08-01","current":-91.060669,"twenty":-60.626235,"median":-39.865155,"eighty":-23.250607,"marketCap":35729110635},{"date":"2025-08-08","current":-184.757225,"twenty":-63.824658,"median":-40.051934,"eighty":-23.50984,"marketCap":32820458238},{"date":"2025-08-15","current":-191.818248,"twenty":-64.911375,"median":-40.112152,"eighty":-23.522344,"marketCap":34074785315},{"date":"2025-08-22","current":-194.469228,"twenty":-72.041871,"median":-40.222554,"eighty":-23.535152,"marketCap":34545708113},{"date":"2025-08-29","current":-184.552827,"twenty":-72.8475,"median":-40.343171,"eighty":-23.581122,"marketCap":32784148770},{"date":"2025-09-05","current":-197.417514,"twenty":-73.864189,"median":-40.425269,"eighty":-23.723244,"marketCap":35069444682},{"date":"2025-09-12","current":-208.147892,"twenty":-74.224679,"median":-40.801852,"eighty":-23.82061,"marketCap":36975599617},{"date":"2025-09-19","current":-212.503459,"twenty":-75.66857,"median":-40.932054,"eighty":-23.865007,"marketCap":37749326897},{"date":"2025-09-26","current":-203.715512,"twenty":-76.587723,"median":-41.008162,"eighty":-23.928977,"marketCap":36188227257},{"date":"2025-10-03","current":-213.916471,"twenty":-77.910534,"median":-41.112345,"eighty":-23.950329,"marketCap":38000335866},{"date":"2025-10-10","current":-208.109485,"twenty":-81.639564,"median":-41.598105,"eighty":-24.044918,"marketCap":36968777077},{"date":"2025-10-17","current":-197.090466,"twenty":-85.2662,"median":-41.668284,"eighty":-24.084563,"marketCap":35011347487},{"date":"2025-10-24","current":-192.138725,"twenty":-87.584871,"median":-41.753651,"eighty":-24.09529,"marketCap":34131715179},{"date":"2025-10-31","current":-191.016991,"twenty":-89.061223,"median":-41.811067,"eighty":-24.120226,"marketCap":33932449287},{"date":"2025-11-07","current":-207.03708,"twenty":-89.680521,"median":-41.96845,"eighty":-24.175905,"marketCap":36778273935},{"date":"2025-11-14","current":594.631071,"twenty":-89.43801,"median":-41.811067,"eighty":-24.044918,"marketCap":40761959883},{"date":"2025-11-21","current":563.847015,"twenty":-89.201535,"median":-41.753651,"eighty":-23.82061,"marketCap":38651712910},{"date":"2025-11-28","current":549.835185,"twenty":-89.104768,"median":-41.685343,"eighty":-23.530029,"marketCap":37691201965},{"date":"2025-12-05","current":534.967794,"twenty":-89.063642,"median":-41.61723,"eighty":-23.184163,"marketCap":36672042310},{"date":"2025-12-12","current":517.921144,"twenty":-88.590694,"median":-41.129457,"eighty":-23.039198,"marketCap":35503494432},{"date":"2025-12-19","current":495.611986,"twenty":-88.19516,"median":-41.047814,"eighty":-22.787779,"marketCap":33974201659},{"date":"2025-12-26","current":503.21518,"twenty":-87.945005,"median":-40.950457,"eighty":-22.473183,"marketCap":34495400571},{"date":"2026-01-02","current":490.430192,"twenty":-87.636143,"median":-40.899758,"eighty":-22.105685,"marketCap":33618989662},{"date":"2026-01-09","current":517.162439,"twenty":-87.22937,"median":-40.570085,"eighty":-21.930759,"marketCap":35451485198},{"date":"2026-01-16","current":546.090088,"twenty":-85.828543,"median":-40.382553,"eighty":-21.503627,"marketCap":37434475537},{"date":"2026-01-23","current":546.929506,"twenty":-85.639801,"median":-40.307741,"eighty":-21.22036,"marketCap":37492017667},{"date":"2026-01-30","current":564.993144,"twenty":-85.550958,"median":-40.153659,"eighty":-20.966373,"marketCap":38730280050},{"date":"2026-02-06","current":560.150346,"twenty":-85.195011,"median":-40.102874,"eighty":-20.825389,"marketCap":38398306221},{"date":"2026-02-13","current":559.214072,"twenty":-84.275105,"median":-39.916618,"eighty":-20.627155,"marketCap":38334124614},{"date":"2026-02-20","current":572.225057,"twenty":-83.309792,"median":-39.846883,"eighty":-20.486836,"marketCap":39226027634},{"date":"2026-02-27","current":124.64483,"twenty":-82.630374,"median":-39.542215,"eighty":-20.122622,"marketCap":35764714896},{"date":"2026-03-06","current":113.265677,"twenty":-81.639564,"median":-39.274234,"eighty":-19.815709,"marketCap":32499660582},{"date":"2026-03-13","current":110.254986,"twenty":-80.905934,"median":-38.936161,"eighty":-19.52935,"marketCap":31635793773},{"date":"2026-03-17","current":111.936055,"twenty":-80.757951,"median":-38.863214,"eighty":-19.498872,"marketCap":32118148147}],"updateTime":1773865784423},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ONC\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1181796814","title":"Stock Track | BEIGENE Plummets 7.45% in Pre-market on Earnings Caution and Below-Guide Revenue Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=1181796814","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181796814?lang=en_us&edition=fundamental","pubTime":"2026-02-26 23:33","pubTimestamp":1772119992,"startTime":"0","endTime":"0","summary":"BEIGENE LTD's American depositary shares experienced a significant pre-market plummet of 7.45% on Thursday, reflecting heavy selling pressure at the market open.The sharp decline comes as the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ONC"],"gpt_icon":0},{"id":"1108917763","title":"Beigene Turns Profit with Strong 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1108917763","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108917763?lang=en_us&edition=fundamental","pubTime":"2026-02-26 21:10","pubTimestamp":1772111443,"startTime":"0","endTime":"0","summary":"Beigene (688235.SH) announced its preliminary financial results for 2025, reporting total operating revenue of 38.205 billion yuan, a 40.4% year-on-year increase. The company achieved net profit...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU1719994722.HKD","LU1303224171.USD","06160","LU1969619763.USD","BK4588","399300","ONC","BK4526","LU0588546209.SGD","159982","LU0307460666.USD","LU1251922891.USD","BK0239","LU1770034418.SGD","BK1588","BK1583","688235","BK4139","BK1500","LU2328871848.SGD","BK4585"],"gpt_icon":0},{"id":"1121119282","title":"BEIGENE Reports Robust 2025 Performance with Adjusted Net Profit of Approximately $918 Million, Turning Around from Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1121119282","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121119282?lang=en_us&edition=fundamental","pubTime":"2026-02-26 19:20","pubTimestamp":1772104829,"startTime":"0","endTime":"0","summary":"BEIGENE (06160) announced its financial results for 2025. In the fourth quarter of 2025, total global revenue reached $1.5 billion, representing a 33% increase year-over-year. For the full year 2025,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","LU1969619763.USD","LU1770034418.SGD","LU1303224171.USD","LU0307460666.USD","BK1500","LU2328871848.SGD","BK4585","BK4139","ONC","BK4588","LU0588546209.SGD","BK4526","LU1719994722.HKD","06160","BK1161","688235","BK1588","BK1583","LU1251922891.USD"],"gpt_icon":0},{"id":"2614010580","title":"GUIDANCE: (ONC) BeOne Medicines Expects 2026 Revenue Range $6.2B to $6.4B, vs. FactSet Est of $6.41B","url":"https://stock-news.laohu8.com/highlight/detail?id=2614010580","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614010580?lang=en_us&edition=fundamental","pubTime":"2026-02-26 19:05","pubTimestamp":1772103937,"startTime":"0","endTime":"0","summary":"GUIDANCE: (ONC) BeOne Medicines Expects 2026 Revenue Range $6.2B to $6.4B, vs. FactSet Est of $6.41B","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ONC","MDCO"],"gpt_icon":0},{"id":"2614010898","title":"Press Release: BeOne Medicines Announces Fourth Quarter and Full Year 2025 Financial Results, Highlighting Global Success of BRUKINSA and Foundational Oncology Leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=2614010898","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614010898?lang=en_us&edition=fundamental","pubTime":"2026-02-26 19:00","pubTimestamp":1772103600,"startTime":"0","endTime":"0","summary":"--  Total global revenues of $1.5 billion and $5.3 billion for the fourth. quarter and full year, increases of 33% and 40% from the prior-year. --  Global BRUKINSA  revenues of $1.1 billion and $3.9. billion for the fourth quarter and full year, increases of 38% and 49%. --  Diluted GAAP Earnings per American Depository Share  of $0.58 and. $2.53 for the fourth quarter and full year; non-GAAP diluted Earnings per. ADS of $1.95 and $8.09 for the fourth quarter and full year. BeOne Medicines Ltd. , a global oncology company, today announced financial results and corporate updates from the fourth quarter and full year 2025.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4139","MDCO","BK4526","ONC"],"gpt_icon":0},{"id":"1152806007","title":"Stock Track | BEIGENE Plunges 6.88% in Pre-market Ahead of 2025 Financial Report Release","url":"https://stock-news.laohu8.com/highlight/detail?id=1152806007","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152806007?lang=en_us&edition=fundamental","pubTime":"2026-02-26 18:39","pubTimestamp":1772102360,"startTime":"0","endTime":"0","summary":"BEIGENE LTD's American depositary shares experienced a significant pre-market plunge of 6.88% as investors showed caution ahead of the company's upcoming financial results announcement.The innovative...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ONC"],"gpt_icon":0},{"id":"1176753689","title":"Stock Track | BEIGENE Plunges 6.83% in 24-Hour Session Ahead of Earnings Report Release","url":"https://stock-news.laohu8.com/highlight/detail?id=1176753689","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176753689?lang=en_us&edition=fundamental","pubTime":"2026-02-26 16:35","pubTimestamp":1772094923,"startTime":"0","endTime":"0","summary":"BEIGENE LTD's stock plunged 6.83% in 24-hour trading, as the innovative drug company faced significant selling pressure. The sharp decline comes as BEIGENE is scheduled to release its 2025 financial...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ONC"],"gpt_icon":0},{"id":"1145787844","title":"Biotech Stocks Lead Declines as BEIGENE Slumps Over 6% Ahead of Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=1145787844","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145787844?lang=en_us&edition=fundamental","pubTime":"2026-02-26 15:22","pubTimestamp":1772090533,"startTime":"0","endTime":"0","summary":"Hong Kong pharmaceutical stocks accelerated their decline during afternoon trading on February 26, with innovative drug industry chain stocks leading the downturn. The Huabao Hang Seng Hong Kong...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"7aeeed2b7873496584fe7f3c4e94617c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU1969619763.USD","520510","ONC","LU0307460666.USD","LU1770034418.SGD","LU1251922891.USD","BK1161","BK1588","BK0239","BK1500","LU1303224171.USD","520880","BK4588","LU2328871848.SGD","159137","BK4139","BK4526","06160","BK1583","688235","LU0588546209.SGD","LU1719994722.HKD"],"gpt_icon":0},{"id":"2613089798","title":"BeOne Medicines AG  expected to post earnings of $1.21 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2613089798","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613089798?lang=en_us&edition=fundamental","pubTime":"2026-02-24 16:02","pubTimestamp":1771920141,"startTime":"0","endTime":"0","summary":"BeOne Medicines AG  expected to post earnings of $1.21 a share - Earnings Preview BeOne Medicines AG ONC.OQ, ONC.O is expected to  show a rise in quarterly revenue when it reports  results on February","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nL8N3ZK0IT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4526","BK4585","BK4588","ONC","BK4139"],"gpt_icon":0},{"id":"1151673050","title":"Earning Preview: BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS this quarter’s revenue is expected to increase by 39.70%, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1151673050","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151673050?lang=en_us&edition=fundamental","pubTime":"2026-02-19 15:46","pubTimestamp":1771487207,"startTime":"0","endTime":"0","summary":"AbstractBEIGENE LTD SPON ADS EACH REPR 13 ORD SHS will release its quarterly results on February 26, 2026, Post Market; this preview compiles consensus expectations, last quarter’s performance,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS this quarter’s revenue is expected to increase by 39.70%, and institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONC"],"gpt_icon":0},{"id":"2610193696","title":"Press Release: BeOne Medicines to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26","url":"https://stock-news.laohu8.com/highlight/detail?id=2610193696","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610193696?lang=en_us&edition=fundamental","pubTime":"2026-02-11 19:01","pubTimestamp":1770807660,"startTime":"0","endTime":"0","summary":"BeOne Medicines Ltd. , a global oncology company, will report its fourth quarter and full year 2025 financial results on Thursday, February 26, 2026 before the financial markets open. Following the release of the financials, the Company will host a live webcast with management at 8:00 a.m. ET.This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws, including statements regarding BeOne's plans, commitments, aspirations and goals related to BeOne's medicines and drug candidates. Actual results may differ materially from those indicated in the forward-looking statements as a result of various important factors which are discussed in the section entitled \"Risk Factors\" in BeOne's most recent periodic report filed with the U.S. Securities and Exchange Commission  as well as discussions of potential risks, uncertainties, and other important factors in BeOne's subsequent filings with","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","MDCO","ONC","BK4585","BK4526","BK4139"],"gpt_icon":0},{"id":"2610653720","title":"Is BeOne Medicines (ONC) Using InSysBio Partnership to Quietly Redefine Its R&D Risk Strategy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2610653720","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610653720?lang=en_us&edition=fundamental","pubTime":"2026-02-09 19:22","pubTimestamp":1770636159,"startTime":"0","endTime":"0","summary":"InSysBio recently announced it has extended its collaboration with BeOne Medicines to apply mechanistic translational modeling to support selection of minimal recommended starting doses, step-up dosing regimens, and dose-escalation clinical study design for cytokine release syndrome risk management.\nThis expanded partnership highlights how advanced modeling can shape early clinical decisions, potentially improving the efficiency and safety profile of BeOne Medicines’ development...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/is-beone-medicines-onc-using-insysbio-partnership-to-quietly","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/is-beone-medicines-onc-using-insysbio-partnership-to-quietly","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MDCO","BK4526","BK4585","BK4139","ONC"],"gpt_icon":0},{"id":"2608336332","title":"Beone Medicines : Barclays Raises Target Price to $394 From $385","url":"https://stock-news.laohu8.com/highlight/detail?id=2608336332","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608336332?lang=en_us&edition=fundamental","pubTime":"2026-02-04 19:25","pubTimestamp":1770204343,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nFWN3Z00TJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ONC","BK0239","688235","BK4585","BK4526","BK4139"],"gpt_icon":0},{"id":"2608543823","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and BeOne Medicines (ONC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2608543823","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608543823?lang=en_us&edition=fundamental","pubTime":"2026-02-04 17:20","pubTimestamp":1770196854,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Amgen (AMGN – Research Report) and BeOne Medicines (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-and-beone-medicines-onc-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-and-beone-medicines-onc-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","IE00BJJMRZ35.SGD","LU0128526141.USD","LU1571399168.USD","IE00B4R5TH58.HKD","LU1983299246.USD","LU1061106388.HKD","BK4534","BK4533","IE00BJT1NW94.SGD","AMGN","LU2242646821.SGD","BK4581","LU0868494617.USD","LU1057294990.SGD","LU2112291526.USD","ONC","LU0029874061.USD","BK4588","LU0058720904.USD","BK4566","BK4585","IE0009355771.USD","IE00BFTCPJ56.SGD","LU2242652126.USD","LU2468319806.SGD","XBI","IE0002141913.USD","BK4139","LU0109394709.USD","BK4599","BK4137","XLV","LU0122379950.USD","SG9999001440.SGD","IE00B2B36J28.USD","LU1023059063.AUD","HCSG","LU2089984988.USD","MDCO","BK4526","LU0289739699.SGD","LU0889565916.HKD","LABU"],"gpt_icon":0},{"id":"2608614330","title":"U.S. RESEARCH ROUNDUP- Ametek, Coca-Cola, Pepsico","url":"https://stock-news.laohu8.com/highlight/detail?id=2608614330","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608614330?lang=en_us&edition=fundamental","pubTime":"2026-02-04 14:59","pubTimestamp":1770188350,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Ametek, Coca-Cola, PepsicoFeb 4 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Ametek, Coca-Cola","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nL8N3Z00I2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABNB","ATI","BC","AMDL","ASH","DOX","AMR","EMR","ADM","BBNX","ARCB","NET","CMG","AMDW","AMUU","BALL","CTMX","DVN","KO","APPN","DOCS","AME","EPD","BRBR","AES","AMDY","BR","PEP","EMN","COLM","AMYY","AMD","CSGP","DY","AMAT","ONC","AMDU","BKNG","BKR","CLX","DVA","AMDD","AMGN","CRUS","AZO","CHD","BHE","AXP","AMDG","CCI"],"gpt_icon":1},{"id":"2608488416","title":"BeOne Medicines Extends InSysBio Tie Up To Refine Oncology Trial Dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=2608488416","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608488416?lang=en_us&edition=fundamental","pubTime":"2026-02-02 01:26","pubTimestamp":1769966782,"startTime":"0","endTime":"0","summary":"BeOne Medicines (NasdaqGS:ONC) has extended its collaboration with InSysBio to apply mechanistic translational modeling to clinical trial design.\nThe partnership targets better dose selection and escalation strategies, with a specific focus on reducing the risk of cytokine release syndrome in upcoming studies.\nThis updated agreement aims to support the company’s clinical development plans for its novel therapies.\n\nFor you as an investor watching BeOne Medicines, the key point is that this is...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/beone-medicines-extends-insysbio-tie-up-to-refine-oncology-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/beone-medicines-extends-insysbio-tie-up-to-refine-oncology-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","BK4585","MDCO","BK4526","ONC"],"gpt_icon":0},{"id":"2608072004","title":"Is There Now An Opportunity In BeOne Medicines (ONC) After Strong Multi‑Year Share Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2608072004","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608072004?lang=en_us&edition=fundamental","pubTime":"2026-01-31 21:25","pubTimestamp":1769865953,"startTime":"0","endTime":"0","summary":"If you are wondering whether BeOne Medicines is attractively priced right now, the key question is how its current share price stacks up against its underlying fundamentals.\nThe stock has returned 0.3% over the last 7 days, 12.0% over 30 days, 9.4% year to date, 51.3% over 1 year and 32.5% over 3 years, while the 5 year return stands at an 8.5% decline.\nThese moves sit against a backdrop of ongoing interest in the pharmaceuticals and biotech space, where investors often react quickly to...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/is-there-now-an-opportunity-in-beone-medicines-onc-after-str","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/is-there-now-an-opportunity-in-beone-medicines-onc-after-str","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MDCO","BK4526","ONC","DCF","BK4585","BK4139"],"gpt_icon":0},{"id":"1111326310","title":"Valuation Ranges of Biopharma: Insights from Innovent Biologics, Hengrui Pharmaceuticals, and BeiGene","url":"https://stock-news.laohu8.com/highlight/detail?id=1111326310","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111326310?lang=en_us&edition=fundamental","pubTime":"2026-01-30 17:06","pubTimestamp":1769763994,"startTime":"0","endTime":"0","summary":"Evaluating Biopharma stocks requires looking beyond traditional metrics, focusing instead on companies that have successfully navigated the entire drug development lifecycle—from molecule discovery...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","LU1781817850.SGD","ONC","BK0188","LU0405327494.USD","BK1589","LU2580892789.USD","LU2580892862.HKD","BK1500","LU0307460666.USD","LU2488822045.USD","BK4139","LU1997245177.USD","LU1655091616.SGD","LU1580142542.USD","LU0359201612.USD","LU2097828474.EUR","LU0588546209.SGD","LU0455707207.USD","LU0359202008.SGD","688235","LU1820825898.SGD","BK1191","BK0028","01801","LU0405327148.USD","LU1064130708.USD","BK0239","LU1770034418.SGD","LU2097828631.EUR","BK4585","BK0012","BK1161","BK0196","LU1969619763.USD","600276","LU0502904849.HKD","BK1588","LU2289578879.USD","LU2242644610.SGD","LU2097828557.USD","LU1719994722.HKD","BK4526","LU1023057109.AUD","BK0060","LU1255011170.USD","LU2097828805.USD","LU1328615791.USD","LU1146622755.USD","LU1064131003.USD","LU1997244956.HKD","LU0359201885.HKD","LU2097828714.EUR","LU2495084118.USD","LU1303224171.USD","LU1997245094.SGD","LU2328871848.SGD","LU1251922891.USD","01276","LU2148510915.USD","06160","LU2543165471.USD","HK0000165453.HKD","BK0183"],"gpt_icon":0},{"id":"1166688867","title":"BeiGene (06160) Grants Restricted Stock Units Involving 21,000 American Depositary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1166688867","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166688867?lang=en_us&edition=fundamental","pubTime":"2026-01-30 17:00","pubTimestamp":1769763627,"startTime":"0","endTime":"0","summary":"BeiGene (06160) announced that on January 23, 2026, the Board's Compensation Committee granted restricted stock units involving a total of 21,000 American Depositary Shares to 246 grantees under the terms of the 2016 Option and Incentive Plan.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","ONC","LU1719994722.HKD","BK1588","BK1583","BK4139","BK4526","LU1969619763.USD","LU1251922891.USD","BK1500","LU1770034418.SGD","LU0588546209.SGD","BK0239","LU1303224171.USD","688235","LU2328871848.SGD","LU0307460666.USD","BK4585","06160"],"gpt_icon":0},{"id":"2606237814","title":"Did BeOne’s New Uptrend And Upgraded Earnings Outlook Just Shift Its (ONC) Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2606237814","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606237814?lang=en_us&edition=fundamental","pubTime":"2026-01-25 02:35","pubTimestamp":1769279753,"startTime":"0","endTime":"0","summary":"Recently, BEONE MEDICINES LTD-ADR (NASDAQ: ONC) met the Minervini Trend Template criteria, signaling a confirmed technical uptrend supported by strong earnings and steady revenue growth.\nAn interesting aspect of this development is the very large increase in analysts’ earnings estimates over the past three months, suggesting growing confidence in BeOne Medicines’ business momentum.\nAgainst this backdrop of rising earnings expectations, we’ll explore how this strengthening technical and...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/did-beones-new-uptrend-and-upgraded-earnings-outlook-just-sh","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/did-beones-new-uptrend-and-upgraded-earnings-outlook-just-sh","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ONC"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":97,"code":"91000000","status":"200"}]}}